Unchanged incidence of microalbuminuria in children with type 1 diabetes since 1986: A UK based inception cohort

Archives of Disease in Childhood

Volumn 94, Issue 4, 2009, Pages 258-262

  Amin, R ^a   Widmer, B ^a   Dalton, R N ^b   Dunger, D B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ANALYSIS OF VARIANCE; ARTICLE; CHILD; COHORT ANALYSIS; GLYCEMIC CONTROL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; AGE OF ONSET; ALBUMINURIA; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; ENGLAND; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 64849088474     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.144337     Document Type: Article

References (33)

1. Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of nephropathy in diabetics. Lancet 1982;2:611.
2. Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004;328:1105.
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-67.
4. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001:134:370-9.
5. Bojestig M, Arnqvist HJ, Karlberg BE, et al. Unchanged incidence of severe retinopathy in a population of type 1 diabetic patients with marked reduction of nephropathy. Diabet Med 1998:15:863-9.
6. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008;336:697-701.
7. Nordwall M, Bojestig M, Arnqvist HJ, et al. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes - the Linkoping Diabetes Complications Study. Diabetologia 2004:47:1266-72.
8. Mohsin F, Craig ME, Cusumano J, et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care 2005;28:1974-80.
9. Bojestig M, Arnqvist HJ, Hermansson G, et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994;330:15-18.
10. Holl RW, Swift PG, Mortensen HB, et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr 2003;162:22-9.
11. Greene AC, Tripaldi M, Chiarelli F, et al. Cross-cultural differences in the management of children and adolescents with diabetes. Horm Res 2002;57(Suppl 1):75-7.
12. The Healthcare Commission. National Diabetes Audit. Report of the period 2004/5. London: The Healthcare Commission, 2006.
13. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 1999;22:495-502.
14. Gardner SG, Bingley PJ, Sawtell PA, et al. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Barfs-Oxford Study Group. BMJ 1997;315:713-17.
15. Olsen BS, Johannesen J, Sj0lie AK, et al. Metabolic control and prevalence of microvascular complications in young Danish patients with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1999;16:79-85.
16. Jones CA, Leese GP, Kerr S, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child 1998;78:518-23.
17. Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria-a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:1309-14.
18. Kullberg CE, Bergstrom A, Dinesen B, et al. Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 1996:19:726-9.
19. Lindblad B. Data from the National Swedish Childhood Diabetes Registry. See http://www.ndr.nu (accessed 28 January 2009).
20. Danne T, Mortensen HB, Hougaard P, et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001;24:1342-7.
21. Litton J, Rice A, Friedman N, et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002;141:490-5.
22. Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-5.
23. Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-8.
24. Amiel SA, Sherwin RS, Simonson DC, et al. Impaired insulin action in puberty. A contributing factorto poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215-19.
25. Amin R, Williams RM, Frystyk J, et al. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Clin Endocrinol (Oxf) 2005;62:137-44.
26. Amin R, Turner C, Van Aken S, et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study. Kidney Int 2005;68:1740-9.
27. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000:43:1205-23.
28. Yip J, Mattock M, Sethi M, et al. Insulin resistance in family members of insulindependent diabetic patients with microalbuminuria. Lancet 1993;341:369-70.
29. Dunger DB, Schwarze CP, Cooper JD, et al. Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 2007:24:131-6.
30. Drummond K, Levy-Marchal C, Laborde K, et al. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children. Diabetologia 1989;32:255-60.
31. Rudberg S, østerby R, Bangstad HJ, et al. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:589-95.
32. Cook J, Daneman D, Spino M, et al. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 1990;117(1 Pt 1):39-45.
33. Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290:1884-90.